Literature DB >> 22232009

Lipids and adipokines as risk factors for Alzheimer's disease.

Matthew W Warren1, Linda S Hynan, Myron F Weiner.   

Abstract

To determine if measures of adipokines and other blood lipids differentiate between normal controls and persons with Alzheimer's disease (AD), we examined levels of leptin, adiponectin, total cholesterol, high density lipoproteins (HDL), calculated low density lipoproteins (LDL), triglycerides and apolipoprotein E allele status in 148 early AD subjects and 198 normal controls. We were unable to demonstrate a significant difference between leptin and adiponectin levels between normal controls and AD subjects. We were able to confirm observations of lower HDL and higher total and LDL cholesterol concentration in AD subjects than in controls. As expected, the presence of the apolipoprotein E4 allele distinguished between the two groups.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22232009      PMCID: PMC3732377          DOI: 10.3233/JAD-2012-111385

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  47 in total

1.  Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.

Authors:  K Fassbender; M Simons; C Bergmann; M Stroick; D Lutjohann; P Keller; H Runz; S Kuhl; T Bertsch; K von Bergmann; M Hennerici; K Beyreuther; T Hartmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface.

Authors:  L Bretillon; D Lütjohann; L Ståhle; T Widhe; L Bindl; G Eggertsen; U Diczfalusy; I Björkhem
Journal:  J Lipid Res       Date:  2000-05       Impact factor: 5.922

3.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

4.  Cholesterol and LDL relate to neuritic plaques and to APOE4 presence but not to neurofibrillary tangles.

Authors:  G T Lesser; M S Beeri; J Schmeidler; D P Purohit; V Haroutunian
Journal:  Curr Alzheimer Res       Date:  2011-05       Impact factor: 3.498

5.  Circulating leptin levels and weight loss in Alzheimer's disease patients.

Authors:  D A Power; J Noel; R Collins; D O'Neill
Journal:  Dement Geriatr Cogn Disord       Date:  2001 Mar-Apr       Impact factor: 2.959

6.  Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.

Authors:  Miia Kivipelto; Eeva-Liisa Helkala; Mikko P Laakso; Tuomo Hänninen; Merja Hallikainen; Kari Alhainen; Susan Iivonen; Arto Mannermaa; Jaakko Tuomilehto; Aulikki Nissinen; Hilkka Soininen
Journal:  Ann Intern Med       Date:  2002-08-06       Impact factor: 25.391

7.  Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity.

Authors:  Alice S Ryan; Dora M Berman; Barbara J Nicklas; Madhur Sinha; Ronald L Gingerich; Grady S Meneilly; Josephine M Egan; Dariush Elahi
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

Review 8.  Brain cholesterol: long secret life behind a barrier.

Authors:  Ingemar Björkhem; Steve Meaney
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-02-05       Impact factor: 8.311

9.  Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.

Authors:  Zaldy Sy Tan; Sudha Seshadri; Alexa Beiser; Peter W F Wilson; Douglas P Kiel; Michael Tocco; Ralph B D'Agostino; Philip A Wolf
Journal:  Arch Intern Med       Date:  2003-05-12

10.  Meal timing, fasting and glucocorticoids interplay in serum leptin concentrations and diurnal profile.

Authors:  Amira Elimam; Claude Marcus
Journal:  Eur J Endocrinol       Date:  2002-08       Impact factor: 6.664

View more
  24 in total

Review 1.  HDL-cholesterol and apolipoproteins in relation to dementia.

Authors:  Manja Koch; Majken K Jensen
Journal:  Curr Opin Lipidol       Date:  2016-02       Impact factor: 4.776

Review 2.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

3.  Leptin and cognition.

Authors:  Matthew W Warren; Linda S Hynan; Myron F Weiner
Journal:  Dement Geriatr Cogn Disord       Date:  2012-07-17       Impact factor: 2.959

4.  Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD).

Authors:  Walter J Lukiw
Journal:  Expert Opin Emerg Drugs       Date:  2012-03-23       Impact factor: 4.191

Review 5.  Body mass index in dementia.

Authors:  S García-Ptacek; G Faxén-Irving; P Cermáková; M Eriksdotter; D Religa
Journal:  Eur J Clin Nutr       Date:  2014-10-01       Impact factor: 4.016

Review 6.  Physiological changes in neurodegeneration - mechanistic insights and clinical utility.

Authors:  Rebekah M Ahmed; Yazi D Ke; Steve Vucic; Lars M Ittner; William Seeley; John R Hodges; Olivier Piguet; Glenda Halliday; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2018-03-23       Impact factor: 42.937

7.  Adipokine pathways are altered in hippocampus of an experimental mouse model of Alzheimer's disease.

Authors:  I Pedrós; D Petrov; G Artiach; S Abad; C Ramon-Duaso; F Sureda; M Pallàs; C Beas-Zarate; J Folch; A Camins
Journal:  J Nutr Health Aging       Date:  2015-04       Impact factor: 4.075

Review 8.  Obesity as a risk factor for Alzheimer's disease: the role of adipocytokines.

Authors:  Liliana Letra; Isabel Santana; Raquel Seiça
Journal:  Metab Brain Dis       Date:  2014-02-20       Impact factor: 3.584

9.  Very old adults with better memory function have higher low-density lipoprotein cholesterol levels and lower triglyceride to high-density lipoprotein cholesterol ratios: KOCOA Project.

Authors:  Yuriko Katsumata; Hidemi Todoriki; Yasushi Higashiuesato; Shotoku Yasura; Yusuke Ohya; D Craig Willcox; Hiroko H Dodge
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 10.  Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment.

Authors:  Sasanka Chakrabarti; Vineet Kumar Khemka; Anindita Banerjee; Gargi Chatterjee; Anirban Ganguly; Atanu Biswas
Journal:  Aging Dis       Date:  2015-08-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.